Ryne Sandberg Shares Details on Prostate Cancer Relapse
Former Chicago Cubs player Ryne Sandberg recently took to social media to share a devastating update regarding his health with his fans. The ex-MLB second baseman first shocked the sporting world in January 2024 when he revealed that he was suffering from metastatic prostate cancer.
Cubs legend Ryne Sandberg shares prostate cancer relapse
Baseball Hall of Famer and Chicago Cubs icon Ryne Sandberg announced on Dec. 10 that his prostate cancer has relapsed and spread to other organs. Sandberg shared the update on Instagram, saying he has resumed intensive treatment and remains determined to fight the disease.
Hosted on MSN2h
Candel Therapeutics Stock More Than Doubles After Strong Prostate Cancer Trial Results: Retail Goes WildShares of Candel Therapeutics surged more than 100% on Wednesday, reaching seven-month highs, as the clinical-stage ...
Prostate cancer vaccines, including dendritic and peptide types, offer hope for improved treatments, but face hurdles in ...
The new blood-based test — called AR-ctDETECT — is designed to detect and analyze small fragments of tumor-derived DNA in the ...
A phase 3 prostate cancer trial of Candel’s oncolytic virus has met its primary endpoint, sending the stock up more than 200% ...
Amid Golden Bachelor Gerry Turner’s diagnosis with an incurable type of cancer, his ex-wife Theresa Nist shared her heartfelt ...
Montell Jordan is advocating for prostate cancer awareness and emphasizing the importance of early detection, particularly ...
Shares of Candel Therapeutics took flight in premarket trading Wednesday after the clinical-stage biopharmaceutical company said a late-stage study of its CAN-2409 product candidate met its key goal ...
A breakthrough study has identified the genetic risk factors that contribute to increased prostate cancer in African men. The ...
Adoption of active surveillance or watchful waiting has been increasing among patients with intermediate-risk prostate cancer ...
Investigators assessed the oncologic benefit of salvage radiation therapy versus observation for men with biochemical recurrence after radical prostatectomy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback